Related Experiment Video
Updated: May 10, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal
Abstract:
Isavuconazole is an extended-spectrum triazole with in vitro activity against a wide variety of fungal pathogens. Clinical isolates of molds Aspergillus lentulus and Neosartorya udagawae and yeast Cryptococcus gattii VGII (implicated in the outbreak in the Pacific Northwest, North America) exhibit reduced susceptibilities to several azoles but higher susceptibilities to isavuconazole.
Insights
Isavuconazole shows effectiveness against challenging fungal infections. This extended-spectrum triazole demonstrates higher activity against resistant molds like Aspergillus lentulus and Neosartorya udagawae, and Cryptococcus gattii.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Triazoles are crucial antifungal agents.
- Emerging fungal pathogens pose treatment challenges.
- Reduced susceptibility to existing azoles is a growing concern.
Purpose of the Study:
- To evaluate the in vitro activity of isavuconazole.
- To assess isavuconazole's efficacy against specific resistant fungal isolates.
- To compare isavuconazole's activity with other azoles.
Main Methods:
- In vitro susceptibility testing.
- Utilized clinical isolates of Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii VGII.
- Minimum Inhibitory Concentration (MIC) determination.
Main Results:
- Isavuconazole demonstrated broad-spectrum in vitro activity.
- Higher susceptibility was observed for Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii VGII to isavuconazole compared to other azoles.
- These specific isolates exhibited reduced susceptibility to several conventional azoles.
Conclusions:
- Isavuconazole is a promising antifungal agent.
- It shows significant in vitro activity against azole-resistant fungal pathogens.
- Isavuconazole may offer a valuable therapeutic option for infections caused by these challenging fungi.
Related Concept Videos
Antifungal Agents
Fungal Phylum Ascomycota
Antimicrobial Effectiveness
Fungal Group Zygomycota
Fungal Phylum Microsporidia

